Related Experiment Video
Updated: May 12, 2026
06:28
E-Patient Counseling Trial (E-PACO): Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
Published on: August 1, 2019
Relationship between medication event rates and the Leapfrog computerized physician order entry evaluation tool.
Alexander A Leung1, Carol Keohane, Stuart Lipsitz
1Division of General Internal Medicine and Primary Care, Brigham and Women's Hospital, Boston, Massachusetts 02120-1613, USA.
Summary
The Leapfrog CPOE evaluation tool effectively monitors computerized physician order entry (CPOE) performance. Higher Leapfrog scores correlate with reduced preventable adverse drug events (ADE), improving patient safety.
Area of Science:
- Health Informatics
- Patient Safety
- Clinical Quality Improvement
Background:
- Computerized Physician Order Entry (CPOE) systems are crucial for medication safety.
- The Leapfrog CPOE evaluation tool aims to assess the effectiveness of CPOE implementation.
- Monitoring CPOE performance is essential for identifying and mitigating risks.
Purpose of the Study:
- To evaluate the relationship between Leapfrog CPOE evaluation tool scores and rates of preventable adverse drug events (ADE) and potential ADE.
- To determine if Leapfrog scores can serve as a reliable indicator of CPOE system performance in reducing ADE.
Main Methods:
- A cross-sectional study involving 1000 adult admissions across five community hospitals.
- Data collected from October 2008 to September 2010.
- Comparison of observed ADE rates with Leapfrog CPOE evaluation tool scores.
Main Results:
- Leapfrog scores showed a strong correlation with preventable ADE rates.
- A 5% increase in Leapfrog scores predicted a 43% relative reduction in preventable ADE.
- Every 5% increase in Leapfrog scores predicted approximately four fewer preventable ADE per 100 admissions.
Conclusions:
- The Leapfrog CPOE evaluation tool is a valuable instrument for monitoring CPOE performance post-implementation.
- Leapfrog scores can help identify hospital vulnerabilities and guide quality improvement efforts in medication safety.
Related Concept Videos
01:30Methods of Documentation VII: EMR
Electronic Medical Records (EMRs) primarily center around electronically documenting patients' health information within a single healthcare organization or practice. They contain essential clinical data related to a patient's medical history, diagnoses, medications, treatment plans, lab results, and other pertinent information relevant to the specific encounter or episode of care. EMRs are designed to streamline documentation and workflow processes within individual healthcare settings,...
01:26Methods of Documentation II: POMR
The Problem-Oriented Medical Record (POMR) revolutionized medical record-keeping by introducing a systematic approach focusing on the patient's problems rather than merely listing symptoms. Dr. Lawrence Weed's introduction of this method in the 1960s marked a significant advancement in medical documentation. The POMR framework consists of four key components: the database, problem list, plan of care, and progress notes.
01:01Dosage Regimens: Partial Pharmacokinetic Parameters
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
01:15Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
01:26Pharmaceutical Poisoning: Potential Scenarios
Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...